| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Panamera Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.83 |
| 52 Week High | US$2.90 |
| 52 Week Low | US$0.56 |
| Beta | 1.39 |
| 11 Month Change | 0% |
| 3 Month Change | -16.99% |
| 1 Year Change | n/a |
| 33 Year Change | -58.91% |
| 5 Year Change | n/a |
| Change since IPO | 453.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHCI | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -2.1% | 1.2% |
| 1Y | n/a | 9.1% | 30.2% |
Return vs Industry: Insufficient data to determine how PHCI performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how PHCI performed against the US Market.
Price Volatility
| PHCI volatility | |
|---|---|
| PHCI Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.1% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: PHCI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PHCI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | T. Jennings | panameraholdings.com |
Panamera Holdings Corporation, together with its subsidiaries, provides consulting services to a healthcare company. The company engages in the scrap metal business. It intends to seek new business opportunities primarily in the environmental services industry, emerging innovative technologies, and individual health choices led by innovation and integration.
Panamera Holdings Corporation Fundamentals Summary
| PHCI fundamental statistics | |
|---|---|
| Market cap | US$37.69m |
| Earnings (TTM) | -US$14.71m |
| Revenue (TTM) | US$100.00k |
376.9x
P/S Ratio-2.6x
P/E RatioIs PHCI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHCI income statement (TTM) | |
|---|---|
| Revenue | US$100.00k |
| Cost of Revenue | US$94.63k |
| Gross Profit | US$5.37k |
| Other Expenses | US$14.72m |
| Earnings | -US$14.71m |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.32 |
| Gross Margin | 5.37% |
| Net Profit Margin | -14,713.14% |
| Debt/Equity Ratio | 1.0% |
How did PHCI perform over the long term?
See historical performance and comparison